Cargando…

Meningococcal burden of disease in Argentina: 10 years epidemiologic review

Invasive meningococcal disease (IMD) is an uncommon but serious and potentially fatal condition, mainly affecting infants. In 2017, Argentina introduced a vaccination program against serogroups A, C, W and Y (MenACWY) for infants aged 3, 5 and 15 months and adolescents aged 11 years. The objective o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyro, Silvina, Urueña, Analia, Efron, Adriana, Rancaño, Carolina, Pannunzio, Maria E., Seoane, Maria B., Gomez, Jorge A., Giglio, Norberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Meningococcal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453991/ https://www.ncbi.nlm.nih.gov/pubmed/37614151 http://dx.doi.org/10.1080/21645515.2023.2237391

Ejemplares similares

Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam
por: The Nguyen, Phung Nguyen, et al.
Publicado: (2023)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination
por: Tan, Litjen (L.J), et al.
Publicado: (2023)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
por: Chacon-Cruz, Enrique, et al.
Publicado: (2022)

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
por: Robertson, Corwin A., et al.
Publicado: (2023)

Meningococcal carriage in the African meningitis belt
Publicado: (2013)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

2476. Impact of the Vaccination Strategy on Varicella Burden Disease in Argentina
por: Neyro, Silvina, et al.
Publicado: (2018)

Estimation of the real burden of invasive meningococcal disease in Argentina
por: Gómez, J. A., et al.
Publicado: (2019)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
por: Dubey, Anand P., et al.
Publicado: (2022)

1382. Varicella Burden Disease in Argentina: 4 Years after National Vaccination Strategy
por: Neyro, Silvina, et al.
Publicado: (2020)

Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies
por: Thisyakorn, Usa, et al.
Publicado: (2022)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
por: Marshall, Gary S., et al.
Publicado: (2022)

Real-world impact and effectiveness of MenACWY-TT
por: Villena, Rodolfo, et al.
Publicado: (2023)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
por: Piazza, Franco M., et al.
Publicado: (2021)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
por: Stefanizzi, Pasquale, et al.
Publicado: (2021)

1435. The Cost-Effectiveness of Vaccinating With an Adjuvanted Trivalent Influenza Vaccine for the 65+ Population in Argentina
por: Nguyen, Van, et al.
Publicado: (2018)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
por: Urueña, Analia, et al.
Publicado: (2021)

Trends in Varicella Burden of Disease Following Introduction of Routine Childhood Varicella Vaccination in Argentina: A 12-Year Time Series Analysis
por: Giglio, Norberto, et al.
Publicado: (2022)

Estimating the health economic impact of the universal varicella vaccination in Argentina from 2015 to 2019
por: Giglio, Norberto, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina
por: Urueña, Analía, et al.
Publicado: (2022)

2326. Enterovirus-Associated Acute Flaccid Myelitis. Argentina′s Nationwide Surveillance of Acute Flaccid Paralysis 2016–2018
por: Pasinovich, Marina, et al.
Publicado: (2019)

Oropharyngeal meningococcal carriage in children and adolescents, a single center study in Buenos Aires, Argentina
por: Gentile, Angela, et al.
Publicado: (2021)

Epidemiological study of influenza virus infections in young adult outpatients from Buenos Aires, Argentina
por: Santamaría, Cecilia, et al.
Publicado: (2008)

Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults
por: Díez-Domingo, Javier, et al.
Publicado: (2021)

Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model
por: Régnier, Stéphane A, et al.
Publicado: (2014)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
por: Stefanizzi, Pasquale, et al.
Publicado: (2022)

Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia
por: Mohammed, Hassen, et al.
Publicado: (2021)

Impact and effectiveness of meningococcal vaccines: a review
por: Helena De Oliveira, Lucia, et al.
Publicado: (2017)

Epidemiology and Clinical Burden of Meningococcal Disease in France: Scoping Review
por: Baloche, Alexiane, et al.
Publicado: (2023)

Single-Dose Universal Hepatitis A Immunization in 1-Year-Old Infants in Argentina: High Prevalence of Protective Antibodies up to 11 Years Following Vaccination
por: Urueña, Analia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ev7ejddkbo9lbug4vqb3vlr2lv